Blog

One of the key roles of pharmacovigilance departments is to understand the benefit-risk profile of a drug. But departments are often bogged down by manual tasks that can absorb time, which might be better spent on value-centric activities. Perhaps the most tedious pharmacovigilance activity is medical literature monitoring (MLM), and as we discussed in our last blog, manual, repetitive tasks are a primary cause of employee dissatisfaction.

During a recent webcast, ArisGlobal carried out an insightful survey, which found that visibility and reporting inefficiencies remain a headache.

Download this white paper to learn about. Pharmacovigilance with an ‘e’ – the “4pt-classification” of the state of evolution of national pharmacovigilance systems Modern technologies in pharmacovigilance system – the way forward for national PV systems Advanced pharmacovigilance technologies –the role ‘e- enablement’ technology plays in bridging the gaps in pharmacovigilance of regulatory authorities across the world

ArisGlobal, a leading provider of integrated cloud-based software solutions for life sciences, announces LifeSphere Publishing and LifeSphere Analytics, new solutions that will integrate with LifeSphere RIMS™ and LifeSphere IDMP™ to offer the most complete, unified platform for regulatory affairs. LifeSphere Publishing delivers streamlined publishing capabilities and content management, and LifeSphere Analytics ensures all reports and analyses will comply with regulatory requirements.

Pharmacovigilance is at a crossroads. The best, most innovative way forward for PV departments may well be automation, as they address the challenges (or market pull factors) and opportunities (or technology push capabilities).

As a medical information software provider, it is necessary to recognize that there is some decent software out there in the life science’s space

Most sponsors and clinical research organisations manage clinical trials using an average of three to five independent core systems. Creating…

Leading Indian CRO enters partnership with ArisGlobal to enhance its delivery capability in operations and biometrics…

This is the second in a three-part blog series on National Pharmacovigilance systems and the role of technology in bridging the gaps in pharmacovigilance of regulatory authorities around the world.

As evident from our second polling question, ”How far along the road would you say you are for a ‘new’ technological revolution,” the journey to capitalize on the next industrial revolution is just beginning for most participants